PharmaSUG2020paper·US·Software Demonstrations (Tutorials)A Single, Centralized, Biometrics Team Focused Collaboration System for Analysis Projects SD-281See metadata
PharmaSUG2020paper·US·Statistics and AnalyticsDiaries and Questionnaires: Challenges and Solutions SA-013See metadata
PharmaSUG2020paper·US·Statistics and AnalyticsA Doctor’s Dilemma: How Propensity Scores Can Help Control For Selection Bias in Medical Education SA-034See metadata
PharmaSUG2020paper·US·Statistics and AnalyticsCalculation of Cochran–Mantel–Haenszel Statistics for Objective Response and Clinical Benefit Rates and the Effects of Stratification Factors SA-051See metadata
PharmaSUG2020paper·US·Statistics and AnalyticsAssigning agents to districts under multiple constraints using PROC CLP SA-072See metadata
PharmaSUG2020paper·US·Statistics and AnalyticsRisk-based and Exposure-based Adjusted Safety Incidence Rates SA-103See metadata
PharmaSUG2020paper·US·Statistics and AnalyticsShould I Wear Pants? And Where Should I Travel in the Portuguese Expanse? Automating Business Rules and Decision Rules Through Reusable Decision Table Data Structures SA-112See metadata
PharmaSUG2020paper·US·Statistics and AnalyticsSample size and HR confidence interval estimation through simulation of censored survival data controlling for censoring rate SA-149See metadata
PharmaSUG2020paper·US·Statistics and AnalyticsA Brief Introduction to Performing Statistical Analysis in SAS, R & Python SA-207See metadata
PharmaSUG2020paper·US·Statistics and AnalyticsPrincipal Stratum strategy for handle intercurrent events: a causal estimand to avoid biased estimates SA-225See metadata
PharmaSUG2020paper·US·Statistics and AnalyticsUsing SAS Simulations to determine appropriate Block Size for Subject Randomization Lists SA-262See metadata
PharmaSUG2020paper·US·Statistics and AnalyticsImplementing Quality Tolerance Limits at a Large Pharmaceutical Company SA-284See metadata
PharmaSUG2020paper·US·Strategic ImplementationMoving A Hybrid Organization Towards CDISC Standardization SI-170See metadata
PharmaSUG2020paper·US·Strategic ImplementationAssessing Performance of Risk-based Testing SI-206See metadata
PharmaSUG2020paper·US·Submission StandardsEnd-to-end Prostate-Specific Antigen (PSA) Analysis in Clinical Trials: From Mock-ups to ADPSA SS-030See metadata
PharmaSUG2020paper·US·Submission StandardsUpdates in SDTM IG V3.3: What Belongs Where – Practical Examples SS-045See metadata
PharmaSUG2020paper·US·Submission StandardsWhy Are There So Many ADaM Documents, and How Do I Know Which to Use? SS-081See metadata